ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Cherokee Pharmaceuticals has signed a five-and-a-half-year deal to supply a fermentation-based product to DuPont Applied BioSciences, which focuses on renewably sourced chemicals. Starting in late 2009, the custom chemical manufacturer will produce the proprietary product at its Riverside, Pa., facility. It bought the plant from Merck & Co. in January 2008 and has been expanding capacity and looking to broaden its customer base. According to Cherokee, the project will tie up a significant proportion of its fermentation capacity.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X